Children frequently receive medicines that are designed for adults. The dose of commercially available products is adapted, mostly based on the child's bodyweight, thereby neglecting differences in pharmacokinetic and pharmacodynamics parameters. If commercial products are unsuitable for administration to children or are unavailable, extemporaneous pharmacy preparations are a good alternative. For this particular population, orodispersible films (ODFs) can be a highly attractive dosage form for the oral administration of drugs. ODFs are relatively easy to prepare in a hospital setting, create dose flexibility, and may suit an individual approach, especially for patients having difficulties in swallowing tablets or being fluid restricted. In...
Lors de cette dernière décennie, le développement de formes pharmaceutiques innovantes permettant d'...
Orally disintegrating tablets (ODTs) are solid dosage forms containing drugs that disintegrate in th...
INTRODUCTION: Pharmaceutical industry is no longer allowed to develop new medicines for use in adult...
Children frequently receive medicines that are designed for adults. The dose of commercially availab...
Children frequently receive medicines that are designed for adults. The dose of commercially availab...
Personalized medicine is becoming increasingly important in contemporary pharmacotherapeutics. If co...
Personalized medicine is becoming increasingly important in contemporary pharmacotherapeutics. If co...
Orodispersible films (ODF) are single or multilayer sheets consisting an edible water-soluble polyme...
Orodispersible films (ODF) hold promise as a novel delivery method, with the potential to deliver ta...
Background: The use of medication in pediatrics, children aged 0-5 years, was explored so as to iden...
Drug development for children has long been a neglected area compared to adult drug development. The...
Background: Children are not small adults, but a vulnerable population with developmental, physiolog...
Children differ from adults in many aspects of pharmacotherapy, including capabilities for drug admi...
In recent years, there has been a tendency toward creating innovative, easy to use and patient-frien...
Drug therapy for children is one of the cornerstone developments that have sharply reduced childhood...
Lors de cette dernière décennie, le développement de formes pharmaceutiques innovantes permettant d'...
Orally disintegrating tablets (ODTs) are solid dosage forms containing drugs that disintegrate in th...
INTRODUCTION: Pharmaceutical industry is no longer allowed to develop new medicines for use in adult...
Children frequently receive medicines that are designed for adults. The dose of commercially availab...
Children frequently receive medicines that are designed for adults. The dose of commercially availab...
Personalized medicine is becoming increasingly important in contemporary pharmacotherapeutics. If co...
Personalized medicine is becoming increasingly important in contemporary pharmacotherapeutics. If co...
Orodispersible films (ODF) are single or multilayer sheets consisting an edible water-soluble polyme...
Orodispersible films (ODF) hold promise as a novel delivery method, with the potential to deliver ta...
Background: The use of medication in pediatrics, children aged 0-5 years, was explored so as to iden...
Drug development for children has long been a neglected area compared to adult drug development. The...
Background: Children are not small adults, but a vulnerable population with developmental, physiolog...
Children differ from adults in many aspects of pharmacotherapy, including capabilities for drug admi...
In recent years, there has been a tendency toward creating innovative, easy to use and patient-frien...
Drug therapy for children is one of the cornerstone developments that have sharply reduced childhood...
Lors de cette dernière décennie, le développement de formes pharmaceutiques innovantes permettant d'...
Orally disintegrating tablets (ODTs) are solid dosage forms containing drugs that disintegrate in th...
INTRODUCTION: Pharmaceutical industry is no longer allowed to develop new medicines for use in adult...